Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Chick Optic Lobe Contains a Developmentally Regulated α2α5β2 Nicotinic Receptor Subtype

Barbara Balestra, Silvia Vailati, Milena Moretti, Wolfang Hanke, Francesco Clementi and Cecilia Gotti
Molecular Pharmacology August 2000, 58 (2) 300-311; DOI: https://doi.org/10.1124/mol.58.2.300
Barbara Balestra
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvia Vailati
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milena Moretti
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfang Hanke
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Clementi
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Gotti
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The most widely expressed neuronal nicotinic acetylcholine receptor subtype in chick brain is that containing the α4 and β2 subunits. However, immunoprecipitation and localization studies have shown that some brain areas also contain the α2 and/or α5 subunits, whose role in the definition of receptor properties is still intriguing. Using subunit-specific polyclonal antibodies, we found that the optic lobe is the chick central nervous system region that expresses the highest level of α2-containing receptors. Immunoprecipitation studies of these immunopurified α2-containing receptors labeled with the nicotinic agonist [3H]epibatidine showed that almost all of them contained the β2 subunit and that more than 66% contained the α5 subunit. Western blot analyses of the purified receptors confirmed the presence of the α2, α5, and β2 subunits and the absence of the α3, α4, α6, α7, α8, β3, and β4 subunits. The α2-containing receptors are developmentally regulated: their expression increases 25 times from embryonic day 7 to posthatching day 1 in the optic lobe, compared with an increase of only 5-fold in the forebrain. The α2-containing optic lobe receptors bind [3H]epibatidine (K d = 29 pM) and a number of other nicotinic agonists with very high affinity and have a pharmacological profile very similar to that of the α4β2 subtype. They form functional cationic channels when reconstituted in lipid bilayers, with pharmacological and biophysical properties different from those of the α4β2 subtype. These channels are activated by nicotinic agonists in a dose-dependent manner and are blocked by the nicotinic antagonist d-tubocurarine.

Footnotes

    • Received January 6, 2000.
    • Accepted May 8, 2000.
  • Send reprint requests to: Dr. Cecilia Gotti, CNR Cellular and Molecular Pharmacology Center, Via Vanvitelli 32, 20129 Milano, Italy. E-mail: Gotti{at}csfic.mi.cnr.it

  • ↵1 This work was supported in part by grants from the Italian Ministry of University and Scientific and Technological Research and the European Program “Training and Mobility of Researchers” (Contract ERB4061PL97–0790).

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 58 (2)
Molecular Pharmacology
Vol. 58, Issue 2
1 Aug 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Chick Optic Lobe Contains a Developmentally Regulated α2α5β2 Nicotinic Receptor Subtype
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Chick Optic Lobe Contains a Developmentally Regulated α2α5β2 Nicotinic Receptor Subtype

Barbara Balestra, Silvia Vailati, Milena Moretti, Wolfang Hanke, Francesco Clementi and Cecilia Gotti
Molecular Pharmacology August 1, 2000, 58 (2) 300-311; DOI: https://doi.org/10.1124/mol.58.2.300

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Chick Optic Lobe Contains a Developmentally Regulated α2α5β2 Nicotinic Receptor Subtype

Barbara Balestra, Silvia Vailati, Milena Moretti, Wolfang Hanke, Francesco Clementi and Cecilia Gotti
Molecular Pharmacology August 1, 2000, 58 (2) 300-311; DOI: https://doi.org/10.1124/mol.58.2.300
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Polypharmacology of CBL0137 in the African Trypanosome
  • Peptide-mediated differential signaling at GPR83
  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics